Coronary Embolic Protection Device Market Analysis, Size, Trends | Global | 2021-2027 | MedCore

  • Year: 2018
  • Scope: 2014-2024
  • Region: Europe, Japan, United States
  • Pages: 909
  • Published Date: 04/02/2018
  • Type: MedCore

Industry Trends

There is a risk that the placement or introduction of a device during an interventional coronary procedure can dislodge thrombi or emboli, which could create health risks for the patient that the interventional procedure is intended to prevent. In response to these concerns, many different approaches were taken to deal with this problem, such as atherectomy, laser angioplasty and the use of thrombolytics. It was found that, when using these approaches, the results were not positive enough to cause a significant decrease in embolization. In response, companies began to develop embolic protection devices (EPDs) that could mechanically capture or aspirate the dislodged plaque.

While the adoption rate for coronary embolic protection devices showed substantial growth in the past, physicians have started to transition away from using embolic protection devices in percutaneous coronary intervention (PCI)procedures. Since the use of embolic protection devices is not completely necessary, and they are not specifically reimbursed, a notable portion of the physicians believe they add unnecessary procedure costs. As a result, the growth of the coronary EPD market has been considerably limited and resulted in market value contractions in recent years. Market value declines are expected to persist over the forecast period, driven by decreasing unit sales and ASP depreciation.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:

  • United States
  • Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
  • Japan


The Only Medical Device Market Research With:

Unit Sales Growth Analysis
Average Selling Prices
Competitor Shares by Segment & Country
 SKU-Level Research Methods
 The Lowest Acquisition Cost

Highly Detailed Segmentation

  • Saphenous Vein Grafts
  • Protection Mechanisms
    • Filter Baskets
    • Distal Balloon Occlusion Devices

*Not all segments covered in each country

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios

Coronary Embolic Protection Device Market Share Insights

In both the US and European coronary embolic protection device markets, Boston Scientific is the market leader. Boston Scientific led the coronary embolic protection device market with its FilterWire EZ™ device, which is a distal filter basket system that can be adapted to different vessel shapes and sizes and can also be preloaded to enhance its deliverability.

Medtronic also holds a significant portion of the United States coronary embolic protection device market. The company currently offers the GuardWire®, which is a combination temporary occlusion and aspiration system indicated for use in SVG interventions. One of the system’s main advantages is its very small crossing profile, making this device a useful alternative where the lesion is difficult to cross due to significant stenosis or tortuosity.

All Companies Analyzed in this Study

  • Abbott
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • W.L. Gore

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled the Interventional Cardiology Market.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology